Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
McKinsey
Accenture
Harvard Business School
Citi
UBS
Baxter
Fish and Richardson

Generated: May 24, 2018

DrugPatentWatch Database Preview

Hydrocodone bitartrate; phenylpropanolamine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for hydrocodone bitartrate; phenylpropanolamine hydrochloride and what is the scope of hydrocodone bitartrate; phenylpropanolamine hydrochloride patent protection?

Hydrocodone bitartrate; phenylpropanolamine hydrochloride
is the generic ingredient in one branded drug marketed by Alpharma Us Pharms and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for hydrocodone bitartrate; phenylpropanolamine hydrochloride.
Summary for hydrocodone bitartrate; phenylpropanolamine hydrochloride

US Patents and Regulatory Information for hydrocodone bitartrate; phenylpropanolamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms CODAMINE hydrocodone bitartrate; phenylpropanolamine hydrochloride SYRUP;ORAL 075103-001 Sep 29, 2000 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Federal Trade Commission
Cerilliant
McKinsey
Colorcon
Citi
Chubb
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.